This article has been updated with quotes from La Jolla Institute President and CSO Mitchell Kronenberg.

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) –The La Jolla Institute for Allergy & Immunology today launched a new center that will focus on using RNAi to study the genetics involved in human diseases and to develop new therapies to combat those maladies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.

Sep
12
Sponsored by
PerkinElmer

This webinar will cover recent advances in the use of CRISPR for generating animal models and cell lines.